Page last updated: 2024-12-08

ompi

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

OMPI: levamisole metabolite; RN given refers to cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID135446
SCHEMBL ID10861413
MeSH IDM0071473

Synonyms (29)

Synonym
4-phenyl-1-(2-sulfanylethyl)imidazolidin-2-one
(+-)-1-(2-mercaptoethyl)-4-phenyl-2-imidazolidinone
2-imidazolidinone, 1-(2-mercaptoethyl)-4-phenyl-, (+-)-
ompi
69158-71-0
dl-2-oxo-3-(2-mercaptoethyl)-5-phenylimidazolidine
1-(2-mercaptoethyl)-4-phenylimidazolidin-2-one
ac57bix3h8 ,
2-oxo-3-(2-mercaptoethyl)-5-phenylimidazolidine
unii-ac57bix3h8
1-(2-mercaptoethyl)-4-phenyl-2-imidazolidinone
32190-33-3
FT-0673432
2-imidazolidinone, 1-(2-mercaptoethyl)-4-phenyl-
levamisole hydrochloride impurity c [who-ip]
rac-(4r)-4-phenyl-1-(2-sulfanylethyl)imidazolidin-2-one [who-ip]
2-oxo-3-(2-mercaptoethyl)-5-phenylimidazolidine, dl-
1-(2-mercaptoethyl)-4-phenyl-2-imdazolidinone
(4rs)-4-phenyl-1-(2-sulfanylethyl)imidazolidin-2-one
levamisole hydrochloride impurity c [ep impurity]
levamisole for veterinary use impurity c [ep impurity]
2-oxo-3-(2-mercaptoethyl)-5-phenylimidazolidine, (+/-)-
SCHEMBL10861413
J-018673
2-oxo-3-(2-mercapto-ethyl)-5-phenylimidazolidine
Q27273854
(+/-)-2-oxo-3-(2-mercaptoethyl)-5-phenylimidazolidine
4-phenyl-1-(2-sulfanylethyl)-4,5-dihydro-1h-imidazol-2-ol
DTXSID50954049
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (83.33)18.7374
1990's1 (16.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 97.13

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index97.13 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.29 (4.65)
Search Engine Demand Index167.63 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (97.13)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (16.67%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (83.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]